The US FDA study is intended to evaluate the system for treating life-threatening ventricular tachyarrhythmias.

The novel design of AtaCor's Atala™ lead aims to provide reliable sensing, antitachycardia pacing (ATP), and shock therapies ...

AtaCor Medical announced today that it entered a financing worth up to $75 million to support its U.S. FDA pivotal study.

has officially released the FY 2026 ICD-10-CM Diagnosis Code Files and ICD-10-PCS Procedure Code Files, marking a significant milestone for sepsis care documentation. The new coding structure, ...

Researchers report favorable safety and efficacy for a combination device after implantation and at 6 months follow-up among ...

Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death in the young, including competitive athletes.1-4 Indeed, the predisposition of patients with this complex form of ...

Targeted ICD selection based on predicted therapy benefit enhances patient outcomes while cutting hospital costs by 16.7%. The study published in the June 2025 issue of Clinical Research in Cardiology ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Improvements in optimal medical therapy for patients with heart failure with reduced ejection fraction (HFrEF) have helped reduce the risk of sudden cardiac death (SCD)—in the modern era, though, just ...

Dr. Patrick Malecha (Medicine): A 69-year-old man with a history of myocardial infarction, ischemic cardiomyopathy, and an implantable cardioverter–defibrillator (ICD) was evaluated because of dyspnea ...

A pacemaker is a small, battery-powered device implanted in your chest to help regulate your heart rate. It consists of two main parts—a pulse generator and leads. Pulse generator: This contains the ...